Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: synchro who wrote (1053)	6/16/1999 1:27:00 AM
From: Walkingshadow	Read Replies (1) \| Respond to of 1686

synchro--- Good post. Thank you. I really hope I don't sound like a BGEN basher; I actually like the company, and largely agree with you. PLUS, let's not forget a couple of other minor details: BGEN has very little debt, is no start-up (approximately $8 billion market cap), has a P/E trailing of 52 (EBAY's is over 2500!), has over 1/2 billion in cash, a gross margin of 86% and a net margin of 25%. AND a pipeline of products, the value of which in comparison to other pipelines has been the subject of discussion here, but I don't think anybody would say the pipeline is worthless or anything close. There may be stronger pipelines in others' stables, but BGEN has a pretty good one also, and as you point out, with BGENs shift to using its own revenues instead of investor money to fund research and product development, this pipeline will likely get better and better. All in all, a strong company getting stronger, I would think. And when you compare these numbers to those of similar companies, I don't think anybody could call you a fool for owning BGEN. Matter of fact, FWIW, I'm about to buy some myself. But, it IS fun to kick things around a bit, eh? :~) Walkingshadow